Medicines prescription patterns in European neonatal units.


Journal

International journal of clinical pharmacy
ISSN: 2210-7711
Titre abrégé: Int J Clin Pharm
Pays: Netherlands
ID NLM: 101554912

Informations de publication

Date de publication:
Dec 2019
Historique:
received: 14 03 2019
accepted: 09 10 2019
pubmed: 19 10 2019
medline: 30 4 2020
entrez: 19 10 2019
Statut: ppublish

Résumé

Background Hospitalized neonates receive the highest number of drugs compared to all other age groups, but consumption rates vary between studies depending on patient characteristics and local practices. There are no large-scale international studies on drug use in neonatal units. Objective We aimed to describe drug use in European neonatal units and characterize its associations with geographic region and gestational age. Setting A one-day point prevalence study was performed as part of the European Study of Neonatal Exposure to Excipients from January to June 2012. Method All neonatal prescriptions and demographic data were registered in a web-based database. The impact of gestational age and region on prescription rate were analysed with logistic regression. Main outcome measure The number and variety of drugs prescribed to hospitalized neonates in different gestational age groups and geographic regions. Results In total, 21 European countries with 89 neonatal units participated. Altogether 2173 prescriptions given to 726 neonates were registered. The 10 drugs with the highest prescription rate were multivitamins, vitamin D, caffeine, gentamicin, amino acids for parenteral nutrition, phytomenadione, ampicillin, benzylpenicillin, fat emulsion for parenteral nutrition and probiotics. The six most commonly prescribed ATC groups (alimentary tract and metabolism, blood and blood-forming organs, systemic anti-infectives, nervous, respiratory and cardiovascular system) covered 98% of prescriptions. Gestational age significantly affected the use of all commonly used drug groups. Geographic region influenced the use of alimentary tract and metabolism, blood and blood-forming organs, systemic anti-infectives, nervous and respiratory system drugs. Conclusion While gestational age-dependent differences in neonatal drug use were expected, regional variations (except for systemic anti-infectives) indicate a need for cooperation in developing harmonized evidence-based guidelines and suggest priorities for collaborative work.

Identifiants

pubmed: 31625122
doi: 10.1007/s11096-019-00923-2
pii: 10.1007/s11096-019-00923-2
doi:

Substances chimiques

Prescription Drugs 0

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1578-1591

Subventions

Organisme : Medical Research Council
ID : MC_G1100158
Pays : United Kingdom

Auteurs

Inge Mesek (I)

Department of Microbiology, University of Tartu, Tartu, Estonia. inge.mesek@ut.ee.

Georgi Nellis (G)

Department of Paediatrics, University of Tartu, Tartu, Estonia.
Neonatal Unit, Children's Clinic, Tartu University Hospital, Tartu, Estonia.

Jana Lass (J)

Department of Microbiology, University of Tartu, Tartu, Estonia.
Pharmacy Department, Tartu University Hospital, Tartu, Estonia.

Tuuli Metsvaht (T)

Department of Paediatrics, University of Tartu, Tartu, Estonia.
Clinic of Anaesthesiology and Intensive Care, Paediatric Intensive Care Unit, Tartu University Hospital, Tartu, Estonia.

Heili Varendi (H)

Department of Paediatrics, University of Tartu, Tartu, Estonia.
Neonatal Unit, Children's Clinic, Tartu University Hospital, Tartu, Estonia.

Helle Visk (H)

Institute of Family Medicine and Public Health, University of Tartu, Tartu, Estonia.

Mark A Turner (MA)

Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
Paediatric Medicines Research Unit (PMRU), Alder Hey Children's NHS Foundation Trust, Liverpool, UK.

Anthony J Nunn (AJ)

Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
Paediatric Medicines Research Unit (PMRU), Alder Hey Children's NHS Foundation Trust, Liverpool, UK.

Jennifer Duncan (J)

Paediatric Medicines Research Unit (PMRU), Alder Hey Children's NHS Foundation Trust, Liverpool, UK.

Irja Lutsar (I)

Department of Microbiology, University of Tartu, Tartu, Estonia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH